Widespread CD4+ T-cell reactivity to novel hTERT epitopes following vaccination of cancer patients with a single hTERT peptide GV1001

Understanding the basis of a successful clinical response after treatment with therapeutic cancer vaccines is essential for the development of more efficacious therapy. After vaccination with the single telomerase (hTERT) 16-mer peptide, GV1001, some patients experienced clinical responses and long-...

Descripción completa

Detalles Bibliográficos
Autores principales: Inderberg-Suso, Else-Marit, Trachsel, Sissel, Lislerud, Kari, Rasmussen, Anne-Marie, Gaudernack, Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2012
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429571/
https://www.ncbi.nlm.nih.gov/pubmed/22934259
http://dx.doi.org/10.4161/onci.20426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429571/
https://www.ncbi.nlm.nih.gov/pubmed/22934259
http://dx.doi.org/10.4161/onci.20426

Ejemplares similares